Farmabase | NEOBASE®

neobase

neobase^®

Neomycin 50%

Effective and safe solution for the treatment of bacterial enteritis of poultry and swine.

NEOBASE^® is a highly concentrated neomycin-based drug with bactericidal activity, highly effective against Gram-negative enterobacteria.

In addition to the high efficacy against enterobacteria, NEOBASE^® shows the following features:

• Excellent solubility;
• Stability in water;
• High fluidity that assures a great miscibility with feed;
• Zero withdrawal period;
• Superior efficacy against unspecific enteritis.

FORMULA

Each 100 g of NEOBASE^® contains:
Neomycin (as sulfate) ……………………….50.0 g
Excipients q.s………………………………….100.0 g

DIRECTIONS FOR USE

Poultry: The recommended dose for the control of enteric diseases in poultry is 20 mg of neomycin, which is equivalent to 40 mg of NEOBASE^® per kilogram of body weight per day, for 5 to 7 consecutive days.

Swine: The recommended dose for the control of enteric diseases in swine is 10 to 20 mg of neomycin, which is equivalent to 20 to 40 mg of NEOBASE^® per kilogram of body weight per day, for 7 consecutive days.

Presentation

200 g Sachet in box with 25 sachets;
20 kg Bag.

Withdrawal Period

A withdrawal period is not required before the slaughter of animals intended for human consumption.

neobase®